-- title: "Highly Pathogenic Avian Influenza (HPAI) H5N1 in Poultry: Clinical Signs and Molecular Surveillance" category: "avian-viruses" metaDescription: "A comprehensive review of HPAI H5N1 pathobiology in poultry, detailing clinical signs, molecular subtyping workflows, and global surveillance strategies using RT-PCR and sequencing." primaryKeyword: "HPAI H5N1 poultry" secondaryKeywords: ["highly pathogenic avian influenza", "clinical signs poultry", "molecular surveillance", "RT-PCR subtyping", "avian influenza clade 2.3.4.4b"]
Highly Pathogenic Avian Influenza (HPAI) H5N1 in Poultry: Clinical Signs and Molecular Surveillance
Introduction
Highly pathogenic avian influenza (HPAI) H5N1 virus of the A/goose/Guangdong/1/1996 lineage continues to represent a major threat to global poultry production and food security. Since the emergence of clade 2.3.4.4b viruses, the epizootic landscape has shifted dramatically, with unprecedented geographic spread and sustained circulation in both wild bird populations and domestic poultry flocks [1, 2, 3]. The clinical presentation of HPAI H5N1 in gallinaceous poultry follows a peracute to acute course characterized by multisystemic vascular and parenchymal damage, driven by the polybasic cleavage site of the hemagglutinin (HA) glycoprotein [4, 5]. Rapid detection, subtyping, and molecular characterization are essential for implementing effective biosecurity and stamping-out protocols.
This article provides an exhaustive literature review of the pathognomonic clinical signs, molecular mechanisms of pathogenicity, and contemporary molecular surveillance techniques for HPAI H5N1 in poultry. Emphasis is placed on the biological and biophysical principles underlying diagnostic assays and the integration of genomic epidemiology into outbreak response.
Pathognomonic Clinical Signs
Peracute Mortality and Onset
The hallmark of HPAI H5N1 infection in susceptible domestic poultry, particularly chickens and turkeys, is the sudden onset of high mortality within 48 to 96 hours post-exposure [3, 5]. Flocks may exhibit mortality rates approaching 100 percent without preceding clinical signs. In broiler operations, a sudden spike in daily mortality and a marked drop in feed and water consumption are often the first indicators of an incursion.
Respiratory and Neurologic Manifestations
Affected birds typically develop severe respiratory distress, including open-mouth breathing, dyspnea, and cyanosis of the comb and wattles. Profuse serous to hemorrhagic nasal and ocular discharge is frequently observed. Neurologic signs, particularly in Galliformes, include torticollis, ataxia, opisthotonos, and paralysis. These signs reflect viral tropism for the central nervous system, a feature mediated by the acquisition of specific mutations in the HA and polymerase basic protein 2 (PB2) genes [1, 7].
Vascultropic Lesions
Intravascular viral replication damages endothelial cells lining the capillary beds, leading to widespread hemorrhage and edema. Subcutaneous hemorrhage of the shanks, petechiation on the proventricular mucosa, and hemoperitoneum are common postmortem findings. The comb and wattles may appear dark purple due to severe congestion and cyanosis. Edema of the head and periorbital tissues, colloquially termed "swollen head syndrome," is a classic feature of HPAI infection in chickens [5, 9].
Diagnosis and Pathological Findings
Gross Pathology
On necropsy, key lesions include diffuse splenomegaly with a mottled appearance, renomegaly with cortical petechiae, and a hemorrhagic tracheal mucosa. The proventriculus, especially at the junction with the gizzard, often exhibits prominent hemorrhagic bands and ecchymoses. Skeletal muscle may show multifocal hemorrhage. Airsacculitis is typically absent in peracute cases but may be present in birds surviving longer [5, 9].
Histopathology
Microscopically, the hallmark lesion is multifocal necrosis of parenchymal cells accompanied by a mild to moderate inflammatory infiltrate. The brain shows non-suppurative encephalitis with perivascular cuffing, gliosis, and neuronal degeneration. Myocardial necrosis and pulmonary congestion are consistent findings. Immunohistochemistry, using monoclonal antibodies against the influenza A nucleoprotein, localizes viral antigen to vascular endothelium, cardiac myocytes, neurons, and renal tubules [1, 5].
Molecular Pathogenesis and Host Response
The HPAI phenotype is conferred by the acquisition of multiple basic amino acids (e.g., R-X-R/K-R) at the HA0 cleavage site. This polybasic motif is recognized by ubiquitous host furin-like proteases and subtilisins, enabling systemic viral replication without the requirement for trypsin-like serine proteases. The result is a pantropic infection that rapidly overwhelms the host [1, 7, 9].
The host response to HPAI H5N1 involves the massive upregulation of pro-inflammatory cytokines and chemokines, a phenomenon termed the "cytokine storm." Recent transcriptomic analysis has identified the role of heat shock proteins (HSPs) via NF-kappaB mediated transcriptional regulation during HPAI infection in chickens [1]. This dysregulated innate immune response correlates with severe tissue damage and mortality.
The PA-X I94V mutation, identified in H7N9 studies, demonstrates that variations in the PA-X protein, a viral endoribonuclease responsible for host shutoff activity, can modulate pathogenicity in both mammalian and avian hosts [13]. While this was characterized in H7N9, the functional principle of PA-X activity is conserved across influenza A subtypes. Mutations in PA-X can alter the balance between viral replication efficiency and host antiviral responses.
Heat Shock Protein Expression and NF-kappaB
So and colleagues demonstrated in 2026 that HPAI H5N1 infection in chickens induces differential expression of HSP70 and HSP90 families through an NF-kappaB dependent pathway [1]. These molecular chaperones are involved in both viral protein folding and modulation of the host apoptotic machinery. This interaction represents a potential target for therapeutic intervention or for monitoring disease progression at the transcriptional level.
Clade 2.3.4.4b Genotype Diversity and Global Circulation
Clade 2.3.4.4b viruses have been responsible for the largest recorded panzootic of HPAI [2, 3, 5]. In the United States, between April 2022 and March 2023, Pennsylvania experienced an outbreak genotype characterized by diverse reassortant constellations involving both Eurasian and North American lineage gene segments [5]. Tewari and colleagues genotyped 40 isolates and identified at least seven distinct genotypes circulating simultaneously, indicating a high degree of viral plasticity.
In France and Egypt, the genetic evolution of H5N1 continues to accelerate, driven in part by co-circulation of H9N2 viruses that supply internal gene segments through reassortment [9, 10]. Concurrent infections with these two subtypes allow the generation of reassortants with altered thermostability, receptor binding affinity, and host range. The interplay between H5N1 and H9N2 is particularly concerning for the evolution of strains with increased fitness in both poultry and mammalian hosts [10].
Molecular surveillance has identified novel reassortant H5N5 viruses in the Pacific Northwest region of the United States, linked to spillover into backyard poultry and fatal human cases [11]. This demonstrates the ongoing risk of antigenic shift even within the HPAI framework.
Molecular Surveillance Techniques
Real-Time RT-PCR Subtyping
Real-time reverse transcription polymerase chain reaction (real-time RT-PCR) is the gold standard for the rapid detection and subtyping of HPAI H5N1. The workflow involves extraction of viral RNA from oropharyngeal or cloacal swabs, followed by amplification using primers and probes targeting the matrix (M) gene for influenza A screening, and specific HA and neuraminidase (NA) gene targets for H5 and N1 subtyping [5, 9].
The biophysical principle of probe-based real-time RT-PCR relies on the 5' nuclease activity of DNA polymerase. When the fluorogenic probe is intact, fluorescence is quenched. Following sequence-specific hybridization and cleavage, the reporter is released, generating a signal proportional to the cumulative amplicon quantity. The threshold cycle (Ct) value provides a semi-quantitative measure of viral RNA load.
For H5 subtyping, primers are designed to flank the polybasic cleavage site region. Sequencing of the amplicon spanning the cleavage site still provides definitive differentiation between HPAI and low pathogenicity avian influenza (LPAI) viruses. Laboratories must adhere to stringent biosafety level 3 (BSL-3) protocols when handling clinical specimens from suspect flocks.
Full-Genome Sequencing and Phylogenetic Analysis
Next-generation sequencing (NGS) of the full viral genome is increasingly incorporated into routine surveillance programs. High-throughput sequencing platforms generate millions of short reads, which are assembled against reference genomes. Single nucleotide polymorphism (SNP) analysis identifies mutations associated with mammalian adaptation (e.g., PB2 E627K, HA Q226L) and antiviral resistance (e.g., neuraminidase inhibitor resistance markers) [5, 10].
Phylogenetic analysis using maximum likelihood or Bayesian methods provides critical insight into the spatial-temporal dynamics of virus spread. By comparing HA gene sequences, clusters of related isolates can be linked to specific introductions from wild birds or from contiguous geographic regions. This phylodynamic approach has been used to reconstruct transmission networks within poultry production systems and to evaluate the effectiveness of control measures [3, 4].
Genotype Classification and Reassortment Tracking
Genotyping of HPAI H5N1 involves determining the lineage of each of the eight gene segments. A genotype designation is assigned based on the specific haplotype combination present. Reassortment events are detected when some segments cluster with Eurasian lineage sequences while others cluster with North American lineage sequences [5]. This tracking is essential for identifying novel genotypes that may have enhanced transmissibility or virulence.
Biosecurity and Depopulation Protocols
Prevention of Viral Entry
Biosecurity measures are the primary defense against HPAI incursion into commercial poultry operations. Core components include the all-in-all-out production system, dedicated footwear and clothing for each barn, and the use of footbaths containing virucidal disinfectants (e.g., quaternary ammonium compounds, peroxygen compounds). Rodent and insect control programs are mandatory given the potential role of fomites in virus transmission. Feed, water, and bedding are protected from contamination by wild bird excrement [3, 8].
Stamping-Out and Depopulation
When HPAI is confirmed in a flock, official veterinary authorities enforce an immediate quarantine and initiate stamping-out procedures. The preferred depopulation method for poultry under these conditions is whole-house gassing with carbon dioxide (CO2) or carbon monoxide (CO). Foam-based depopulation systems that generate small bubble foam or high expansion foam are also approved in certain jurisdictions. After depopulation, carcasses are composted, incinerated, or rendered in a manner that prevents viral dissemination [3].
Environmental Surveillance and Decontamination
Environmental sampling of litter, dust, and water sources around affected premises is performed to confirm the removal of infectious virus. Disinfection protocols involve the sequential application of detergent followed by disinfectant. Downtime periods, during which no susceptible poultry are present, are mandated for a minimum of 21 days. Sentinel birds are sometimes introduced before restocking to verify that the premises are free of HPAI [8].
One Health and the Role of Companion Animals and Other Species
HPAI H5N1 is not restricted to avian hosts. Spillover events involving domestic cats have been documented in Germany in early 2026 [7]. Serologic evidence of infection has also been identified in veterinary professionals exposed to infected companion animals [12]. The susceptibility of felids to HPAI is consistent with the presence of avian-type sialic acid receptors in the feline respiratory tract. While this review focuses on poultry, the ability of HPAI to infect mammals underscores the importance of molecular surveillance across species boundaries.
The emergence of H5N1 in dairy cattle, described separately in an article on this portal, extends the host range further [8, 4]. Computational modeling of multihost transmission dynamics now incorporates data from livestock, wild birds, and humans [4].
Current Outbreak Dynamics and Future Directions
HPAI H5N1 clade 2.3.4.4b continues to exhibit a pronounced seasonal pattern in temperate regions, driven by wild waterfowl migration. The virus is now considered endemic in certain European and Asian wild bird populations, making eradication from poultry extremely challenging [2, 3]. Outbreak investigations increasingly rely on rapid genomic characterization to differentiate field strains from vaccine-derived virus in regions that have adopted vaccination strategies, such as Finland [6].
The diversity of H5N1 genotypes detected in Pennsylvania [5] and the concurrent circulation of H5N1 and H9N2 in Egypt [10] indicate that the evolutionary trajectory of these viruses is accelerating. The development of computational frameworks for identifying novel antiviral targets, such as PA endonuclease inhibitors, represents a promising avenue for both therapeutic and prophylactic applications [14].
A summary of key clinical signs and diagnostic methods is provided below.
| Clinical Sign | Pathophysiology | Diagnostic Method |
|---|---|---|
| Sudden high mortality | Systemic endothelial damage, multiorgan failure | Real-time RT-PCR (M gene screening) |
| Cyanosis of comb/wattles | Vascular thrombosis, hemorrhage | Gross pathology |
| Hemorrhagic proventriculus | Capillary necrosis | Necropsy, histopathology |
| Torticollis, ataxia | Viral encephalitis | Histopathology, IHC |
| Edema of head and periorbital tissues | Increased vascular permeability | Clinical observation |
A decision tree for molecular surveillance of suspect HPAI outbreaks is illustrated in Figure 1.
flowchart TD
A[Clinical suspicion: sudden mortality, respiratory/neurologic signs], > B[Collection of oropharyngeal and cloacal swabs]
B, > C[RNA extraction]
C, > D{Real-time RT-PCR: M gene}
D, >|Negative| E[Exclude influenza A]
D, >|Positive| F{HS subtype test}
F, >|H5 negative| G[Perform H7/H9 subtyping]
F, >|H5 positive| H{Cleavage site sequencing}
H, >|Polybasic cleavage site| I[Confirm HPAI H5N1]
H, >|Monobasic cleavage site| J[Characterize as LPAI]
I, > K[Full-genome NGS; genotype assignment]
K, > L[Phylogenetic analysis and risk assessment]
L, > M[Report to veterinary authority; initiate biosecurity and depopulation]
References
So JR, Truong AD, Nguyen TU, et al. HPAIV-induced heat shock protein expression in chickens and its potential NF-kappaB mediated transcriptional regulation. Vet Immunol Immunopathol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42241795/
Hamunyela E, Coetzee L, Marcacci M, et al. Highly pathogenic avian influenza H5N1 virus outbreak among common terns (Sterna hirundo) in Namibia, 2025-2026. Vet Ital. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42237945/
Powell MR. Temporal analysis of highly pathogenic avian influenza H5N1 in commercial and non-commercial flocks in the United States; 2022-2025. Risk Anal. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42227147/
Adiga A, Chopra A, Wilson ML, et al. A high-resolution, US-scale digital similar of interacting livestock, wild birds, and human ecosystems for multihost epidemic spread. Proc Natl Acad Sci U S A. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42207910/
Tewari D, Sekhwal MK, Nicholson C, et al. Genotype diversity of highly pathogenic avian influenza H5N1 clade 2.3.4.4b in Pennsylvania poultry during disease outbreak from April 2022 to March 2023. Viruses. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42198705/
Härmä V, Palsola M, Kuusipalo A, et al. Lessons from the 2024 avian influenza vaccination campaign in Finland: a qualitative inquiry. Vaccine. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42167136/
Dressler A, Wagner-Wiening C, Tegtmeyer B, et al. Highly pathogenic avian influenza A(H5N1) in poultry and domestic cats and occupational exposure among veterinary and other first responders, Germany, February 2026. Euro Surveill. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42141860/
Oremush R, Aubry P, Parmley EJ, et al. Determining the environmental and ecological factors associated with poultry farm spillover of highly pathogenic avian influenza (H5N1) in British Columbia, Canada. Zoonoses Public Health. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42136541/
Briand FX, Martenot C, Massin P, et al. Re-emergence of a highly pathogenic avian influenza H5N1 virus of clade 2.3.4.4b in poultry in France. Infect Genet Evol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42107481/
Yehia N, Ibrahim M, Shady RM, et al. Concurrent circulation of avian influenza viruses H5N1 and H9N2 enhances the genetic evolution of reassortant viruses in Egyptian poultry populations. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42102049/
Kibiger L, Oltean HN, Leitz L, et al. Fatal human case of highly pathogenic avian influenza A(H5N5) in a backyard flock owner - Washington, November 2025. MMWR Morb Mortal Wkly Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42096351/
Vaughan A, Joyce A, Traub E, et al. Serologic evidence of highly pathogenic avian influenza A(H5N1) virus infection in a veterinary professional exposed to an infected domestic cat - Los Angeles County, California, December 2024-January 2025. MMWR Morb Mortal Wkly Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42096344/
Chen X, Liu H, Jiang L, et al. PA-X I94V mutation modulates the pathogenicity of the highly pathogenic H7N9 influenza A virus in mice and chickens. Vet Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42090884/
Vlasiou MC. A One Health computational framework for identifying PA endonuclease inhibitors against contemporary H5N1 avian influenza. Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42076757/
Cordero-Ortiz M, Solís-Hernández M, Cayetano-Mondragón M, et al. Antibody recognition of highly and low-pathogenic A/H5Nx influenza viruses in sera of Mexican donors. Pathogens. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42075679/